Beijing Kawin Technology Share-Holding Co.,Ltd

About Beijing Kawin Technology Share-Holding Co.,Ltd

Focusing on viral and immune diseases, Kawin can offer matured products based upon our specialty in interferon strain management, in EP standard. We also can provide product licensing opportunities like our portfolio of Glycyrrhizin products that have been popularized in dermatology and hepatology.  Transfer of Interferon & GCSF (both conventional & pegylated) are open to discussion.

  • CN
  • 2023
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Biopharmaceutical company
Primary activities
API Producer
Biopharmaceutical
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
  • No.6 Rongjing East Street, BDA, Beijing, China, 100176, Beijing, China
Meet us at

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024

Products from Beijing Kawin Technology Share-Holding Co.,Ltd (5)